Report
Jonathan Moreland
EUR 9.34 For Business Accounts Only

InsiderInsights Daily Ratings Report: October 16, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
A-Mark Precious Metals, Inc.

Appian

Appian provides low-code automation platform that accelerates the creation of business applications, enabling its customers to automate their business. The company's platform automates the creation of forms, data flows, records, reports and other software elements that would otherwise need to be manually coded. The company'snSelf-Assembling Interface Layer technology ensures that applications developed on its platform can be deployed across a range of mobile and desktop devices, including desktop web browsers, tablets and mobile phones. The company's platform can be deployed in the cloud or on-premises, with organizations able to access the same functionality and data sources in various cases.

ASPEN GROUP INC

Barings BDC Inc.

Barings BDC and its wholly-owned subsidiaries are specialty finance companies. The company operates as a closed-end, non-diversified investment company.

Bassett Furniture Industries Inc.

Bassett Furniture Industries is a retailer, manufacturer and marketer of branded home furnishings. The company's products are sold primarily through a network of the company-owned and licensee-owned branded stores under the Bassett Home Furnishings (BHF) name. The company's wholesale home furnishings segment is involved principally in the design, manufacture, sourcing, sale and distribution of furniture products to a network of BHF stores and independent furniture retailers. The company's Retail segment includes its store network of the company-owned stores and licensee-owned stores. The company's Logistical Services segment provides network line haul freight (middle mile) and warehousing, distribution and inventory management.

CorMedix Inc.

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's primary focus is on the development of its key product candidate, Neutrolin

Hanesbrands Inc.

Hanesbrands is a marketer of basic innerwear and activewear apparel in the Americas, Europe, Australia and Asia/Pacific under some apparel brands, including Hanes, Champion, Bonds, DIM, Maidenform, Bali, Playtex, Lovable, Bras N Things, Nur Die/Nur Der, Alternative, L'eggs, JMS/Just My Size, Wonderbra, and Gear for Sports. The company's segments are: Innerwear, which includes apparel products, such as men's underwear, women's panties, children's underwear, socks and intimate apparel; Activewear, which includes T-shirts, fleece, performance apparel, sport shirts and thermals; and International, which includes innerwear, activewear, hosiery and home goods products, sold outside of the United States.

Iteris

Iteris is a provider of applied informatics that enable smart transportation and digital agriculture. The company has three segments: Roadway Sensors, which provides detection sensors and systems for traffic intersection management, communication systems and roadway traffic data collection applications; Transportation Systems, which includes engineering and consulting services focused on the planning, design, development and implementation of software and hardware-based intelligent transportation systems; and Agriculture and Weather Analytics, which consists of its ClearPath Weather and ClearAg solutions.

Seres Therapeutics

Seres Therapeutics is a microbiome therapeutics platform company developing a class of biological drugs, which it refers to as Ecobiotic? microbiome therapeutics. SER-287 is being developed to treat ulcerative colitis, or UC. SER-109 is designed to reduce recurrences of Clostridium difficile infection, or CDI, a debilitating infection of the colon, in patients who have received antibiotic therapy for recurrent CDI by treating the dysbiosis of the colonic microbiome. In addition, using its microbiome therapeutics platform, the company is developing product candidates to treat diseases including SER-301, a rationally designed, fermented UC candidate, and SER-401, a microbiome therapeutic candidate.

The E.W. Scripps Company

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch